????????? ???????? ?? ??? ?????? ????? ???????? ??????? ?????? ?????? ????? ???????? ??????? ?????? is predicted to reach USD 124.39 million with a CAGR of 9.15% till 2030. Early toxicity testing is a pivotal procedure that involves assessing the potential harmful effects or toxicity of drugs, chemicals, or substances at their initial stages of development. ??? ?????? ???????: ???-?????? ??????? ??????? : There is an increasing shift in Canada towards non-animal testing methods for early-stage toxicity testing, driven by both ethical considerations and regulatory requirements. This includes the use of in vitro, organ-on-chip, and in silico models (computer simulations) that provide more human-relevant data compared to traditional animal testing. ?????? ??????’? ????? ?? ?????? : Regulatory bodies in Canada, such as Health Canada and the Canadian Environmental Assessment Agency (CEAA), are placing a growing emphasis on the development and use of alternative toxicity testing methods that align with international standards for reducing animal use in toxicity testing. https://www.nextmsc.com/report/canada-early-toxicity-testing-market